ClinVar Miner

Submissions for variant NM_030962.3(SBF2):c.4666T>C (p.Phe1556Leu) (rs189911105)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000701432 SCV000830233 uncertain significance Charcot-Marie-Tooth disease type 4 2018-01-11 criteria provided, single submitter clinical testing This sequence change replaces phenylalanine with leucine at codon 1556 of the SBF2 protein (p.Phe1556Leu). The phenylalanine residue is moderately conserved and there is a small physicochemical difference between phenylalanine and leucine. This variant is present in population databases (rs189911105, ExAC 0.01%). This variant has not been reported in the literature in individuals with SBF2-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories RCV000757738 SCV000886076 uncertain significance not provided 2018-05-07 criteria provided, single submitter clinical testing The SBF2 c.4666T>C; p.Phe1556Leu variant (rs189911105), to our knowledge, is not reported in the medical literature, gene specific variation databases, nor has it been previously identified by our laboratory. This variant is listed in the genome Aggregation Database (gnomAD) with an overall population frequency of 0.002% (identified on 4 out of 242,768 chromosomes). The phenylalanine at position 1556 is moderately conserved, considering 11 species, and computational analyses of the effects of the p.Phe1556Leu variant on protein structure and function do not predict a deleterious effect (SIFT: tolerated, PolyPhen-2: benign). Based on the available information, the clinical significance of the p.Phe1556Leu variant cannot be determined with certainty.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.